Cutting monkeypox vaccine dosage is no easy fix, officials say
A new dose-sparing technique to extend the US supply of Bavarian Nordic’s monkeypox vaccine has been met with widespread safety concerns, with the vaccine maker’s CEO expressing ”reservations” about the method.
By Madison Muller, bloomberg
The US government’s solution to the monkeypox vaccine shortage is so far only causing headaches for strained public health departments as the outbreak continues to grow in scale and scope.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
